About Event
Why attend the 2nd Biophysics for Drug Discovery Summit?
This summit brings together drug discovery senior decision makers and biophysicists to explore the latest research and technology applications in case study presentations.
Uniting senior decision makers from across drug discovery with expert biophysicists, this summit explores the latest research and applications of established and evolving technologies.
Capitalize on this opportunity to network with senior biophysicist from leading pharmaceutical and biotechnology companies, share ideas, and collaborate on strategies for better hit selection, characterization and target identification. Hear from industry leaders including Pfizer, AstraZeneca, Sanofi, Roche, Amgen, Foghorn Therapeutics and Stablix as they share their latest insights and strategies. Join us to shape the future of drug discovery.
Join Your Peers To:
Explore the application of biophysical techniques from fragment-based drug discovery to single-particle tracking and uncover applications across emerging modalities such as protein degraders, allowing the industry to to go after once previously deemed “undruggable” targets from Novartis and Foghorn Therapeutics
Harness AI, virtual screening, and automation in conjunction with biophysical assays to accelerate hit-to-lead optimization from Novo-Nordisk, AI Protein, and the Institute of Cancer Research
Hear from AstraZeneca, Sanofi, and Pfizer how they are overcoming challenges in the application of biophysical techniques for characterization to extract key lessons learned and harness transferable insights to accelerate your drug development
Explore advanced biophysical techniques including in-cell biophysics and single-particle tracking to gain critical insights for hit-to-lead from UCB, Roche, and NYU
Who Will You Meet?
Meet and network with 60+ senior Biophysicists who are leading drug discovery across a range of therapeutic areas and modalities, including experts from Pfizer, AstraZeneca, Sanofi, Roche, Amgen, Foghorn Therapeutics. Gain valuable insights into novel modalities, strategies and the applications of technologies to accelerate your drug discovery research.
What Your Peers Have to Say
“The amalgamation of different approaches to tackle some of the most challenging biophysics problems was a standout for me. 1-1 interactions with different scientists and leaders from different companies was a great opportunity to exchange ideas.”
Associate Director, Accent Therapeutics